Connect your AI

QuidelOrtho Corporation QDEL Total Equity

Total Equity at other companies

AbbottABT

$52.06B+6.7%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

DanaherDHR

$52.95B+4.1%

RevvityRVTY

$7.18B-5.9%

Quest DiagnosticsDGX

$7.37B+6.3%

Opko HealthOPK

$1.2B-8.2%

Other financials

Income statement

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total assets$5.6B-12.9%

Cash flow

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

Market cap$832.61M-56.1%

Enterprise value$3.8B-22.0%

P/S0.3×-0.4×

Profitability

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is QuidelOrtho Corporation's total equity?: QuidelOrtho Corporation (QDEL) reported total equity of $1.85B in Q1 2026.
How has QuidelOrtho Corporation's total equity changed year-over-year?: QuidelOrtho Corporation's total equity decreased by 38.2% year-over-year, from $3B to $1.85B.
What is the long-term trend for QuidelOrtho Corporation's total equity?: Over 5 years (2020 to 2025), QuidelOrtho Corporation's total equity has grown at a 7.6% compound annual growth rate (CAGR), from $1.33B to $1.92B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.